Publication
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Journal Paper/Review - Nov 27, 2019
van den Bent Martin, Zhang Hefei, Balbin O Alejandro, Vicente Sergio, Cheng Yi, Kirsilae Tiina, Zhao Sylvia, Tiedt Ralph, Rodón Jordi, Tabatabai Ghazaleh, Jörger Markus, Lassman Andrew B, Wen Patrick Y, Yung W K Alfred, Sepulveda Juan, De Vos Filip, Azaro Analia, Wick Wolfgang
van den Bent, Martin
1
0
Azaro, Analia
2
0
De Vos, Filip
1
0
Sepulveda, Juan
1
0
Yung, W K Alfred
1
0
Wen, Patrick Y
2
0
Lassman, Andrew B
1
0
Jörger, Markus
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I
189
48
Tabatabai, Ghazaleh
6
0
Rodón, Jordi
4
0
Tiedt, Ralph
2
0
Zhao, Sylvia
1
0
Kirsilae, Tiina
1
0
Cheng, Yi
1
0
Vicente, Sergio
1
0
Balbin, O Alejandro
1
0
Zhang, Hefei
1
0
Wick, Wolfgang
11
0